Ambu appoints Britt Meelby Jensen new CEO

Juan Jose Gonzalez steps down as chief executive of Ambu on May 20, as Britt Meelby Jensen assumes charge. (Updated)

Britt Meelby Jensen | Photo: Atos Medical

Effective tomorrow, May 20, Juan Jose Gonzalez will no longer be the chief executive of Danish medtech firm Ambu, the firm has announced in a press release.

His place at the helm will be taken over by Britt Meelby Jensen, who has been a board member of Ambu since 2019, a position she leaves as part of the executive reshuffle. She has also previously served in a similar role as CEO of Swedish Atos Medical, until the company was sold off to Coloplast in early 2022.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs